LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
KLRSCIK 0001754068

Kalaris Therapeutics, Inc.

21 transactions by 14 insiders, from December 18, 2025 to August 27, 2026.

Transactions
2114 insiders
Bought · P
$6.2Mopen market
Sold · S
$13Kopen market
Net
+$6.2Mnet buying

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Srinivas AkkarajuDir7—$6.2M—
Brett R. HagenCAO2——$13K
David HallalDir1———
Morana Jovan-EmbiricosDir1———
Michael DybbsDir1———
Laurie KeatingDir1———
Matthew FeinsodCMO1———
Napoleone FerraraDir1———
Andrew OxtobyOfficer1———
Matthew GallCFO1———
Liisa Ann BaykoCFO1———
Leone D. PattersonDir1———
Amy O'Leary VandekopCAO1———
Anthony P. AdamisDir1———

All transactions

21 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Amy O'Leary VandekopCAODERIVAug 27A10,000$0.00—?
Laurie KeatingDirDERIVAug 1A18,000$0.00—?
Liisa Ann BaykoCFODERIVJul 20A220,000$0.00—?
Leone D. PattersonDirDERIVJun 3A9,000$0.00—?
Morana Jovan-EmbiricosDirDERIVJun 3A9,000$0.00—?
David HallalDirDERIVJun 3A9,000$0.00—?
Napoleone FerraraDirDERIVJun 3A9,000$0.00—?
Michael DybbsDirDERIVJun 3A9,000$0.00—?
Srinivas AkkarajuDirDERIVJun 3A9,000$0.00—?
Anthony P. AdamisDirDERIVJun 3A9,000$0.00—?
Srinivas AkkarajuDirJOINTMay 20J4,471$0.00—
Srinivas AkkarajuDirJOINTMay 20J14,937$0.00—
Srinivas AkkarajuDirJOINTMay 20J66,906$0.00—
Srinivas AkkarajuDirJOINTMay 20P244,300$4.83$1.2M
Brett R. HagenCAODERIVMar 19A60,800$0.00—?
Brett R. HagenCAOMar 20S1,915$6.72$13K
Andrew OxtobyOfficerDERIVMar 19A222,000$0.00—?
Matthew GallCFODERIVMar 19A95,000$0.00—?
Matthew FeinsodCMODERIVMar 19A135,000$0.00—?
Srinivas AkkarajuDirJOINTDec 18P479,847$10.42$5.0M
Srinivas AkkarajuDirJOINTDec 22A1,500,000$10.00$15.0M